AI. Telemedicine. Quantum. New Novartis Boss Says Tech Will Finally Change The Drug Biz - (Forbes via NewsPoints Desk)

  • Novartis CEO Vas Narasimhan suggested that new technology will fuel the evolution of the pharmaceutical industry, Forbes reported Monday.

  • "We enter a world where we do some things better than we used to, but fundamentally, we've not rethought how we do clinical trials," commented Narasimhan, adding "so we really approach it from the perspective of 'How could we use technology just to leapfrog many of the challenges?'"

  • Novartis was one of the earliest investors in Science 37, a start-up firm seeking to use telemedicine to send medicines and nurses to patients' homes, while the drugmaker is also working with Flatiron Health, a company focused on making data from electronic health records more relatable.

  • The drugmaker also partnered with Pear Therapeutics earlier this month to develop programme to help patients manage schizophrenia and multiple sclerosis symptoms.

  • Although Novartis has launched more drugs over the last decade than any other pharmaceutical company, Narasimham wants the drugmaker to make "smart, contrarian bets," such as its decision in 2012 to licence Kymriah.

  • "I would say it's a long road, and that's not something I'm going to see," the CEO stated, continuing "I'm a young man. I'll do my best during my term."

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.